Santen Pharmaceutical Co Ltd 2023 Sustainability Report
The report describes Santen's group-wide sustainability governance and a March 2023 review of 13 materialities, which identified market penetration of products with social significance and human resource development and promotion as the two most important. It reports a commitment to net-zero greenhouse gas emissions by 2050 and a Scope 1 and Scope 2 reduction roadmap. It also highlights the Blind Experience Advanced Course, with 3,885 participants and a 91% participation rate as of April 1, 2023.
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Sustainability Report
Pages: 11
Back to company
Santen Pharmaceutical Co Ltd
Sustainability Strategy
The report describes Santen's group-wide sustainability governance and a March 2023 review of 13 materialities, which identified market penetration of products with social significance and human resource development and promotion as the two most important. It reports a commitment to net-zero greenhouse gas emissions by 2050 and a Scope 1 and Scope 2 reduction roadmap. It also highlights the Blind Experience Advanced Course, with 3,885 participants and a 91% participation rate as of April 1, 2023.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Net Zero Target